Join us for an insightful video that delves into findings from provider surveys and patient chart audits, uncovering practice patterns, attitudes, and barriers to evidence-based biomarker testing in advanced/metastatic NSCLC management at both community and academic medical centers. Additionally, we’ll explore biomarker testing, the clinical efficacy and safety data on FDA-approved therapies for specific driver mutations, along with expert recommendations for managing adverse events associated with targeted therapies. Take the lessons with you using the downloadable NSCLC Biomarker Toolkit, developed in collaboration with leading experts and designed to be a point-of-care resource for clinicians.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/moving-needle-advancing-evidence-based-nsclc-management-strategies
- Start Date: 2024-07-31 05:00:00
- End Date: 2024-07-31 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: Janssen (Any division) - Amount: 120000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest